![]() | License: Creative Commons Attribution 4.0 PDF - Published Version (787kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-537408
- DOI to cite this document:
- 10.5283/epub.53740
Abstract
Background Patients with COVID-19 and severe acute respiratory failure may require veno-venous extracorporeal membrane oxygenation (VV ECMO). Yet, this procedure is resource-intensive and high mortality rates have been reported. Thus, predictors for identifying patients who will benefit from VV ECMO would be helpful. Methods This retrospective study included 129 patients with COVID-19 and ...

Owner only: item control page